Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Injectable cryogels can deliver drugs and aid tissue repair with minimal surgery.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

HIV can cause unusual and severe skin problems that are hard to treat.

Blood tests confirmed a baby in the womb had a CMV infection.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Phyllanthus emblica leaves show potential for developing new antimalarial drugs with low toxicity.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

New methods are being developed to improve drug delivery to the brain.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.